Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin adjunctive therapy for hospitalized influenza with lower respiratory tract infection
ISRCTN11273879Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 4 trial of clarithromycin in influenza and pulmonary infection (2 arms), sponsored by The University of Hong Kong. Primary endpoint: 30-day mortality. Started Feb 2015; status: completed.
02
Drugs
clarithromycin
03
Conditions
influenzapulmonary infection
Beyond the preview
Go deeper on ISRCTN11273879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11273879.